Tiziana Life Sciences PLC (LON:TILS – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 58.50 ($0.74) and traded as high as GBX 59 ($0.75). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.74), with a volume of 297,127 shares.
Tiziana Life Sciences Stock Up 8.3 %
The company has a debt-to-equity ratio of 2.36, a current ratio of 6.54 and a quick ratio of 6.41. The stock’s 50 day simple moving average is GBX 58.50 and its two-hundred day simple moving average is GBX 58.50. The firm has a market cap of £113.85 million and a P/E ratio of -3.59.
About Tiziana Life Sciences
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
Further Reading
- Five stocks we like better than Tiziana Life Sciences
- Stock Market Upgrades: What Are They?
- Gilead Sciences Stock Surges on HIV Treatment Trial Success
- Top Biotech Stocks: Exploring Innovation Opportunities
- Dell and Super Micro Computer: Musk’s Favorite AI Hardware Stocks
- When to Sell a Stock for Profit or Loss
- Top 3 Home Builder Stocks: Key Insights into the Housing Market
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.